These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12440487)

  • 1. Raised circulating interleukin-18 levels in reactive AA-amyloidosis.
    Maury CP; Tiitinen S; Laiho K; Kaarela K; Liljeström M
    Amyloid; 2002 Jun; 9(2):141-4. PubMed ID: 12440487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
    Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
    Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
    Bokarewa M; Abrahamson M; Levshin N; Egesten A; Grubb A; Dahlberg L; Tarkowski A
    J Rheumatol; 2007 Jun; 34(6):1293-301. PubMed ID: 17552057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloidosis is frequently undetected in patients with rheumatoid arthritis.
    Koivuniemi R; Paimela L; Suomalainen R; Tornroth T; Leirisalo-Repo M
    Amyloid; 2008 Dec; 15(4):262-8. PubMed ID: 19065298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is interleukin-18 useful for monitoring rheumatoid arthritis?
    Bokarewa M; Hultgren O
    Scand J Rheumatol; 2005; 34(6):433-6. PubMed ID: 16393763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
    Lard LR; Roep BO; Toes RE; Huizinga TW
    J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis.
    Kawashima M; Novick D; Rubinstein M; Miossec P
    Arthritis Rheum; 2004 Jun; 50(6):1800-5. PubMed ID: 15188356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
    de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
    Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
    Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
    Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC; Chung SJ; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis].
    Okuda Y; Yamada T; Takasugi K; Takeda M; Nanba S; Onishi M; Miyamoto T; Inoue Y
    Ryumachi; 1999 Feb; 39(1):3-10. PubMed ID: 10332210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An AA-amyloidosis course in patients with rheumatoid arthritis].
    Sarkisova IA; Rameev VV; Varshavskiĭ VA; Golitsyn EP; Kozlovskaia LV
    Ter Arkh; 2006; 78(5):31-6. PubMed ID: 16889046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis.
    Rooney T; Murphy E; Benito M; Roux-Lombard P; FitzGerald O; Dayer JM; Bresnihan B
    Ann Rheum Dis; 2004 Nov; 63(11):1393-8. PubMed ID: 15479888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
    Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
    J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
    Maury CP; Wegelius O
    Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.